Literature DB >> 6752353

Cellular basis for accumulation of In-111-labeled leukocytes and platelets in rejecting cardiac allografts: concise communication.

T S Wang, S Oluwole, R A Fawwaz, M Wolff, N Kuromoto, K Satake, M A Hardy, P O Alderson.   

Abstract

Biodistribution and imaging studies in rats showed that In-111-labeled leukocytes and platelets accumulate progressively with time after transplantation in cardiac allografts undergoing rejection, but do not accumulate in normal syngeneic heart grafts. Maximum heart allograft-to-blood ratios of 9:1 were obtained, and allograft-to-native heart ratios of 17:1. Microscopic studies of the rejecting cardiac allografts showed that histologic findings paralleled the cellular changes predicted by the radionuclide studies. Intravenously administered Ga-67 citrate and Tc-99m sulfur colloid failed to show significant accumulation in rejecting grafts. The findings suggest that cellular rejection, rather than nonspecific inflammatory changes, is the primary basis for accumulation of In-111 leukocytes and platelets in rejecting cardiac allografts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752353

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Diagnosis of cardiac allograft rejection by the detection of circulating plasma cardiac myosin light chains.

Authors:  M Kawauchi; Y Yazaki; T Oka; H Okabe; M Mathison; J Nakajima; O Morizuki; G Kawaguchi; K Koseni; M Takeda
Journal:  Jpn J Surg       Date:  1990-03

2.  [125I] radioiodinated metaraminol: a new platelet-specific labeling agent.

Authors:  Y Ohmomo; A Yokoyama; K Kawai; Y Arano; K Horiuchi; C Tanaka; H Saji; K Torizuka
Journal:  Eur J Nucl Med       Date:  1985

3.  201Tl myocardial perfusion in the management of the transplanted heart.

Authors:  J Richter; J Herreros; A Serena; M Domper; J C Ramirez; A Gómez; R Arcas
Journal:  Eur J Nucl Med       Date:  1990
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.